Join us on Tuesday, April 29th, 3pm CEST, for an in-depth exploration of the importance of AI-powered biomarker discovery and precision diagnostics.
.jpg?width=960&height=540&name=BioLizard%20Webinar%20-%20Hero%20Image%20(1).jpg)
As the volume and complexity of biomedical data continue to grow, extracting actionable insights that directly impact patient outcomes remains a critical challenge for the life sciences sector. The integration of AI in bioinformatics is transforming how biomarkers are discovered and developed.
In this interactive webinar, the team of data scientists will be complemented by a clinician to provide perspective on how these advancements are clinically relevant and applicable with the goal of improving patient care.
Why attend?
-
Discover how AI-powered bioinformatics and multi-omics integration are revolutionizing biomarker discovery.
-
Learn from a real-world case study (Tutivia™) how advanced RNA signature analysis and machine learning can improve risk stratification and support clinical decision-making for patient care.
-
See how next-generation platforms like Bio|Verse™ empower researchers to seamlessly analyze, integrate, and visualize complex biomedical data, accelerating the journey from data to actionable insights.
Expert speakers include:
-
Moderator: Alexander Koch, PhD, Team Lead Bioinformatics, BioLizard
-
Volodimir Olexiouk, PhD, Director Services & Solutions, BioLizard
-
Patti Connolly, COO, Verici Dx
-
Nehal Doshi, Principal Bioinformatics Scientist, Verici Dx
-
Zahraa Hajjiri, Medical Director of Transplant Nephrology at the University of Illinois at Chicago
Don’t miss this opportunity to explore how AI-powered biomarker discovery is transforming precision medicine and diagnostics and how it is shaping the future of healthcare innovation.
Register for the webinar here.
